Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Risk factors for vascular dementia: Hypotension as a key point

Authors Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Published 11 April 2008 Volume 2008:4(2) Pages 395—402


Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Department of Internal Medicine and Clinical Neurology University of Trieste, Italy

Abstract: Physiologically, the cerebral autoregulation system allows maintenance of constant cerebral blood flow over a wide range of blood pressure. In old people, there is a progressive reshape of cerebral autoregulation from a sigmoid curve to a straight line. This implies that any abrupt change in blood pressure will result in a rapid and significant change in cerebral blood flow. Hypertension has often been observed to be a risk factor for vascular dementia (VaD) and sometimes for Alzheimer disease although not always. Indeed, high blood pressure may accelerate cerebral white matter lesions, but white matter lesions have been found to be facilitated by excessive fall in blood pressure, including orthostatic dysregulation and postprandial hypotension. Many recent studies observed among other data, that there was a correlation between systolic pressure reduction and cognitive decline in women, which was not accounted for by other factors. Baseline blood pressure level was not significantly related to cognitive decline with initial good cognition. Some researchers speculate that blood pressure reduction might be an early change of the dementing process. The most confounding factor is that low pressure by itself might be a predictor of death; nevertheless, the effect of low blood pressure on cognition is underestimated because of a survival bias. Another explanation is that clinically unrecognized vascular lesions in the brain or atherosclerosis are responsible for both cognitive decline and blood pressure reduction. We discuss the entire process, and try to define a possible mechanism that is able to explain the dynamic by which hypotension might be related to dementia.

Keywords: vascular dementia, hypotension, low blood pressure, alzheimer disease

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Depression in vascular pathologies: the neurologist's point of view

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G

Vascular Health and Risk Management 2011, 7:433-443

Published Date: 12 July 2011

Readers of this article also read:

Magnetic particle imaging: kinetics of the intravascular signal in vivo

Haegele J, Duschka RL, Graeser M, Schaecke C, Panagiotopoulos N, Lüdtke-Buzug K, Buzug TM, Barkhausen J, Vogt FM

International Journal of Nanomedicine 2014, 9:4203-4209

Published Date: 3 September 2014

Epidemiology of stroke in a rural community in Southeastern Nigeria

Enwereji KO, Nwosu MC, Ogunniyi A, Nwani PO, Asomugha AL, Enwereji EE

Vascular Health and Risk Management 2014, 10:375-388

Published Date: 24 June 2014

Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors

Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, Martynova MG, Bystrova OA, Yakovenko IV, Ischenko AM

International Journal of Nanomedicine 2014, 9:273-287

Published Date: 3 January 2014

Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome

Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, et al

Vascular Health and Risk Management 2010, 6:571-578

Published Date: 5 July 2010

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials

Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia

Vascular Health and Risk Management 2009, 5:411-427

Published Date: 8 May 2009

ST segment depression in hypertensive patients: A comparison of exercise test versus Holter ECG

Sakir Uen, Rolf Fimmers, Burkhard Weisser, Osman Balta, Georg Nickenig, Thomas Mengden

Vascular Health and Risk Management 2008, 4:1073-1080

Published Date: 10 October 2008

Clinical efficacy and safety of statins in managing cardiovascular risk

Navin K Kapur, Kiran Musunuru

Vascular Health and Risk Management 2008, 4:341-353

Published Date: 11 April 2008